Abstract:METTL14 promotes the proliferation, invasion and migration of nasopharyngeal carcinoma cells. METTL14 enhances ANKRD22 mRNA stability and translation through the m6A‐IGF2BP2 dependent pathway. ANKRD22 binds to SLC25A1 to promote lipid metabolism reprogramming, leading to the upregulation of proliferation, invasion and migration‐related gene expression via enhancing H3K27AC, which in turn activates METTL14 transcription. Background N6‐methyladenosine (m6A) modification is essential for modulating RNA processing as well as expression, particularly in the context of malignant tumour progression. However, the exploration of m6A modification in nasopharyngeal carcinoma (NPC) remains very limited. Methods RNA m6A levels were analysed in NPC using m6A dot blot assay. The expression level of methyltransferase‐like 14 (METTL14) within NPC tissues was analysed from public databases as well as RT‐qPCR and immunohistochemistry. The influences on METTL14 expression on NPC proliferation and metastasis were explored via in vitro as well as in vivo functional assays. Targeted genes of METTL14 were screened using the m6A and gene expression profiling microarray data. Actinomycin D treatment and polysome analysis were used to detect the half‐life and translational efficiency of ANKRD22. Flow cytometry, immunofluorescence and immunoprecipitation were used to validate the role of ANKRD22 on lipid metabolism in NPC cells. ChIP‐qPCR analysis of H3K27AC signalling near the promoters of METTL14, GINS3, POLE2, PLEK2 and FERMT1 genes. Results We revealed METTL14, in NPC, correlating with poor patient prognosis. In vitro and in vivo assays indicated METTL14 actively promoted NPC cells proliferation and metastasis. METTL14 catalysed m6A modification on ANKRD22 messenger ribonucleic acid (mRNA), recognized by the reader IGF2BP2, leading to increased mRNA stability and higher translational efficiency. Moreover, ANKRD22, a metabolism‐related protein on mitochondria, interacted with SLC25A1 to enhance citrate transport, elevating intracellular acetyl‐CoA content. This dual impact of ANKRD22 promoted lipid metabolism reprogramming and cellular lipid synthesis while upregulating the expression of genes associated with the cell cycle (GINS3 and POLE2) and the cytoskeleton (PLEK2 and FERMT1) through heightened epigenetic histone acetylation levels in the nucleus. Intriguingly, our findings highlighted elevated ANKRD22‐mediated histone H3 lysine 27 acetylation (H3K27AC) signals near the METTL14 promoter, which contributes to a positive feedback loop perpetuating malignant progression in NPC. Conclusions The identified METTL14‐ANKRD22‐SLC25A1 axis emerges as a promising therapeutic target for NPC, and also these molecules may serve as novel diagnostic biomarkers.

ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3

As an Independent Unfavorable Prognostic Factor, IL-8 Promotes Metastasis of Nasopharyngeal Carcinoma Through Induction of Epithelial–mesenchymal Transition and Activation of AKT Signaling

EZH2-DNMT1-mediated Epigenetic Silencing of Mir-142-3p Promotes Metastasis Through Targeting ZEB2 in Nasopharyngeal Carcinoma

HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma

NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription

Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability.

Epigenetic Mediated Zinc Finger Protein 671 Downregulation Promotes Cell Proliferation and Tumorigenicity in Nasopharyngeal Carcinoma by Inhibiting Cell Cycle Arrest.

NOTCH2 Negatively Regulates Metastasis and Epithelial-Mesenchymal Transition Via TRAF6/AKT in Nasopharyngeal Carcinoma

A transcriptomic analysis based on aberrant methylation levels revealed potential novel therapeutic targets for nasopharyngeal carcinoma

The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling

The M6a Methyltransferase METTL3 Affects Autophagy and Progression of Nasopharyngeal Carcinoma by Regulating the Stability of Lncrna ZFAS1

m 6 A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression

LncRNA EPB41L4A-AS2 Represses Nasopharyngeal Carcinoma Metastasis by Binding to YBX1 in the Nucleus and Sponging MiR-107 in the Cytoplasm

RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma

Upregulation of PNCK Promotes Metastasis and Angiogenesis Via Activating NF-κB/VEGF Pathway in Nasopharyngeal Carcinoma

YPEL3 Suppresses Epithelial–mesenchymal Transition and Metastasis of Nasopharyngeal Carcinoma Cells Through the Wnt/β-catenin Signaling Pathway

DNAJA4 suppresses epithelial-mesenchymal transition and metastasis in nasopharyngeal carcinoma via PSMD2-mediated MYH9 degradation

Data from <i>rab37</i> Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma

The oncogenic role of HIF-1α/miR-182-5p/ZFP36L1 signaling pathway in nasopharyngeal carcinoma

METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m6A modification of ANKRD22 mRNA

Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.